These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6736276)

  • 1. Clinical relevance of thiothixene plasma levels.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychopharmacol; 1984 Jun; 4(3):155-7. PubMed ID: 6736276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiothixene plasma levels and clinical response in acute schizophrenia.
    Reifler BV; Ward N; Davis CM; Freidel RO
    J Clin Psychiatry; 1981 May; 42(5):207-11. PubMed ID: 7217026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels.
    Yesavage JA
    Biol Psychiatry; 1982 Nov; 17(11):1331-7. PubMed ID: 7150681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.
    Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level monitoring of thiothixene in schizophrenia: acute single-dose levels at fixed doses.
    Yesavage JA; Becker J; Werner PD; Mills MJ; Holman CA; Cohn R
    Am J Psychiatry; 1982 Feb; 139(2):174-8. PubMed ID: 7055286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene.
    Kim DY; Hollister LE
    J Clin Psychopharmacol; 1984 Feb; 4(1):32-5. PubMed ID: 6693581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluphenazine plasma levels and clinical response.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychiatry; 1984 Sep; 45(9):370-3. PubMed ID: 6381472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of thiothixene by radioreceptor assay: clinical usefulness.
    Van Putten T; May PR; Marder SR; Wilkins JN; Rosenberg BJ
    Psychopharmacology (Berl); 1983; 79(1):40-4. PubMed ID: 6403963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays.
    Yesavage JA; Holman CA; Cohn R; Lombrozo L
    Arch Gen Psychiatry; 1983 Mar; 40(3):301-4. PubMed ID: 6830409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial.
    Burnett GB; Little SR; Graham N; Forrest AD
    Dis Nerv Syst; 1975 Nov; 36(11):625-9. PubMed ID: 1102277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels and clinical effects of thioridazine and thiothixene.
    Bergling R; Mjorndal T; Oreland L; Rapp W; Wold S
    J Clin Pharmacol; 1975; 15(2-3):178-86. PubMed ID: 1091665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary attempt to relate individual differences in EEG test dose response to clinical effect.
    May PR; Itil T; Van Putten T; Lee MA; Yale C
    Biol Psychiatry; 1982 May; 17(5):599-603. PubMed ID: 7093395
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of neuroleptics on attention in adolescent schizophrenics.
    Erickson WD; Yellin AM; Hopwood JH; Realmuto GM; Greenberg LM
    Biol Psychiatry; 1984 May; 19(5):745-53. PubMed ID: 6733182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of loxapine succinate in acute schizophrenia: a comparative study with thiothixene.
    van der Velde CD; Kiltie H
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):1-12. PubMed ID: 806422
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
    Ngui PW; Teo SH
    Singapore Med J; 1971 Aug; 12(4):227-32. PubMed ID: 5129906
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiothixene in schizophrenic psychoses.
    Vinar O; Taussigová D; Bastecký J
    Act Nerv Super (Praha); 1971; 13(3):174-7. PubMed ID: 4939830
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiothixene. Its range of therapeutic activity.
    Oliveros RT; Ban TA; Lehmann HE; Sterlin C; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):26-9. PubMed ID: 4909376
    [No Abstract]   [Full Text] [Related]  

  • 20. Thiothixene and the thioxanthenes.
    Ban TA; Lehmann HE
    Adv Biochem Psychopharmacol; 1974; 9(0):481-6. PubMed ID: 4836220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.